Revvity (RVTY) risk factors, FY2024 10-K

Revvity's FY2024 10-K, filed Feb 25, 2025, lists 20 risk factors in 6 groups. There is no earlier 10-K to compare against, so the most company-specific risks are listed below.

Risk factors listed
206 groups
Section length
6k wordsItem 1A

Revvity's biggest risks in the FY2024 10-K

  • Revvity relies heavily on international sales, which generated a majority of its 2024 revenue.
  • The company carries $9.1 billion in net intangible assets, including goodwill and patents.
  • Operations depend on single or limited-source suppliers for critical raw materials and components.

The risks most specific to Revvity

  • Risks Related to our Business Operations and Industry

    A significant disruption in third-party package delivery and import/export services, or significant increases in prices for those services, could interfere with our ability to ship products, increase our costs and lower our profitability

    A significant disruption in package delivery services like UPS, FedEx, TNT, or DHL could interfere with product shipments and increase costs.

  • Risks Related to our Business Operations and Industry

    Disruptions in the supply of raw materials, certain key components and other goods from our limited or single source suppliers could have an adverse effect on the results of our business operations, and could damage our relationships with customers

    Disruptions from single or limited-source suppliers of critical raw materials and components could harm operations and customer relationships.

  • Risks Related to our Business Operations and Industry

    Our success also depends on our ability to execute leadership succession plans. The inability to successfully transition key management roles could have a material adverse effect on our operating results

    Security breaches, cybercrime, or IT system failures could result in unauthorized access, asset transfers, or ransom demands.

  • Risks Related to our Business Operations and Industry

    Our results of operations will be adversely affected if we fail to realize the full value of our intangible assets

    Failure to realize the full value of $9.1 billion in net intangible assets, including goodwill and patents, would adversely affect operations.

  • Risks Related to Legal, Government and Regulatory Matters

    The healthcare industry is highly regulated and if we fail to comply with its extensive system of laws and regulations, we could suffer fines and penalties or be required to make significant changes to our operations which could have a significant adverse effect on the results of our business operations

    Non-compliance with extensive healthcare and genetic screening regulations could result in fines, penalties, and mandatory operational changes.

  • Risks Related to our Foreign Operations

    Economic, political and other risks associated with foreign operations could adversely affect our international sales and profitability

    International operations generated a majority of 2024 revenue, exposing the company to foreign business, economic, and political risks.

  • Risks Related to our Debt

    Restrictions in our senior unsecured revolving credit facility and other debt instruments may limit our activities

    Restrictions in the revolving credit facility and multiple senior unsecured notes due through 2051 may limit business activities.

  • Risks Related to Ownership of our Common Stock

    Dividends on our common stock could be reduced or eliminated in the future

    Quarterly dividends of $0.07 per share declared in late 2024 and early 2025 could be reduced or eliminated in the future.

All 20 risk factors

Headings as the filing states them, in filing order.

Risks Related to our Business Operations and Industry

  1. 01Our growth and profitability are subject to global economic and political conditions, and operational disruptions at our facilities
  2. 02If we do not introduce new products in a timely manner, we may lose market share and be unable to achieve revenue growth targets
  3. 03We may not be able to successfully execute acquisitions or divestitures, license technologies, integrate acquired businesses or licensed technologies into our existing businesses, maintain licensed technologies, or make acquired businesses or licensed technologies profitable
  4. 04If we do not compete effectively, our business will be harmed
  5. 05Our quarterly operating results could be subject to significant fluctuation, and we may not be able to adjust our operations to effectively address changes we do not anticipate, which could increase the volatility of our stock price and potentially cause losses to our shareholders
  6. 06A significant disruption in third-party package delivery and import/export services, or significant increases in prices for those services, could interfere with our ability to ship products, increase our costs and lower our profitability
  7. 07Disruptions in the supply of raw materials, certain key components and other goods from our limited or single source suppliers could have an adverse effect on the results of our business operations, and could damage our relationships with customers
  8. 08If we do not retain our key personnel, our ability to execute our business strategy will be limited
  9. 09Our success also depends on our ability to execute leadership succession plans. The inability to successfully transition key management roles could have a material adverse effect on our operating results
  10. 10Our results of operations will be adversely affected if we fail to realize the full value of our intangible assets

Risks Related to our Intellectual Property

  1. 11We may not be successful in adequately protecting our intellectual property
  2. 12If we are unable to renew our licenses or otherwise lose our licensed rights, we may have to stop selling products or we may lose competitive advantage

Risks Related to Legal, Government and Regulatory Matters

  1. 13The manufacture and sale of products and services may expose us to product and other liability claims for which we could have substantial liability
  2. 14Changes in governmental regulations may reduce demand for our products or increase our expenses
  3. 15The healthcare industry is highly regulated and if we fail to comply with its extensive system of laws and regulations, we could suffer fines and penalties or be required to make significant changes to our operations which could have a significant adverse effect on the results of our business operations

Risks Related to our Foreign Operations

  1. 16Economic, political and other risks associated with foreign operations could adversely affect our international sales and profitability

Risks Related to our Debt

  1. 17We have a substantial amount of outstanding debt, which could impact our ability to obtain future financing and limit our ability to make other expenditures in the conduct of our business
  2. 18Restrictions in our senior unsecured revolving credit facility and other debt instruments may limit our activities

Risks Related to Ownership of our Common Stock

  1. 19Our share price will fluctuate
  2. 20Dividends on our common stock could be reduced or eliminated in the future

Other Revvity 10-Ks

  • FY2025 10-K risk factors
    21 risks1 new4 reworded

    AI deployment is newly identified as a business, operational, cost, competitiveness, and reputation risk.

    Filed Feb 24, 2026

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.